Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sulfasalazine pneumonitis.

B H Yaffe, B I Korelitz

    The American Journal of Gastroenterology
    |August 1, 1983
    PubMed
    Summary

    Sulfasalazine can cause lung disease in patients with Crohn's disease. This drug-induced lung injury presents with cough, fever, and shortness of breath, resolving after medication withdrawal.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    6-mp and azathioprine for Crohn's disease: how long do you keep a good thing going?

    Inflammatory bowel diseases·2013
    Same author

    Anorectal Crohn's disease: surgical and medical management.

    BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
    Same author

    Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.

    Gut·2005
    Same author

    Is there any remaining role for methotrexate for Crohn's disease?

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2003
    Same author

    Postendoscopy syndrome: "the doctor never talked to me".

    Journal of clinical gastroenterology·2001
    Same author

    Colchicine for persistent constipation after total abdominal colectomy with ileorectostomy for colonic inertia.

    Journal of clinical gastroenterology·2001

    Area of Science:

    • Pulmonology
    • Gastroenterology
    • Pharmacology

    Background:

    • Sulfasalazine is a common treatment for inflammatory bowel diseases like Crohn's disease.
    • Adverse drug reactions can manifest in various organ systems, including the lungs.

    Observation:

    • A patient with Crohn's disease developed respiratory symptoms including cough, dyspnea, and fever.
    • Clinical presentation was associated with peripheral eosinophilia and bilateral pulmonary infiltrates.

    Findings:

    • The patient's symptoms and radiographic findings resolved completely after discontinuing sulfasalazine.
    • This clinical course strongly suggests sulfasalazine-induced lung disease.

    Implications:

    • Clinicians should consider sulfasalazine-induced lung disease in patients with Crohn's disease presenting with unexplained pulmonary symptoms.
    • Early recognition and drug withdrawal are crucial for favorable outcomes in drug-induced lung injury.